CD151 immunoreactivity at diagnosis predicts early biochemical failure and metastasis in prostate cancer

被引：0
|
作者：
Vasquez, Catalina [1 ]
Martinez, Carlos [1 ]
Chan, Susanne [2 ]
Chalasani, Venu [1 ]
Gomez-Lemus, Jose [2 ]
Williams, Andrew [1 ]
Chin, Joseph [3 ]
Zijlstra, Andries [4 ]
Lewis, John [1 ]
机构：
[1] Univ Western Ontario, Translat Prostate Canc Res Grp, London, ON, Canada
[2] Univ Western Ontario, Dept Pathol, Translat Prostate Canc Res Grp, London, ON, Canada
[3] Univ Western Ontario, Dept Oncol, London Hlth Sci Ctr, Translat Prostate Canc Res Grp, London, ON, Canada
[4] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-2260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2260
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Nuclear morphology predicts prostate cancer metastasis at diagnosis
    Huang, Fangjin
    Ing, Nathan
    Miller, Eric N.
    Salemi, Hootan
    Lewis, Michael S.
    Garraway, Isla P.
    Gertych, Arkadiusz
    Knudsen, Beatrice S.
    CANCER RESEARCH, 2018, 78 (13)
  • [22] CD151 promotes cancer cell metastasis via integrins α3β1 and α6β1 in vitro
    Fei, Yujie
    Wang, Ji
    Liu, Weifeng
    Zuo, Houjuan
    Qin, Jin
    Wang, Daowen
    Zeng, Hesong
    Liu, Zhengxiang
    MOLECULAR MEDICINE REPORTS, 2012, 6 (06) : 1226 - 1230
  • [23] Separation of tetraspanin CD151 from its integrin partner α3β1 reflects an altered migratory state and predicts prostate cancer progression
    Palmer, T. D.
    Vasquez
    Hebron, K.
    Arnold, S. A.
    Giannico, G. A.
    Ketova, T.
    Lewis, J. D.
    Zijlstra, A.
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (03) : 253 - 253
  • [24] Separation of tetraspanin CD151 from its integrin partner α3β1 reflects an alter migratory state and predicts prostate cancer progression
    Palmer, Trenis
    Martinez, Carlos
    Vasquez, Catalina
    Hebron, Katie
    Arnold, Shanna
    Jones-Paris, Celestial
    Chan, Susanne
    Chalasani, Venu
    Gomez-Lemus, Jose
    Williams, Andrew
    Chin, Joseph
    Giannico, Giovanna
    Ketova, Tatiana
    Lewis, John
    Zijlstra, Andries
    CANCER RESEARCH, 2014, 74 (19)
  • [25] CD151 promotes breast cancer metastasis by activating TGF-β1/Smad signaling pathway
    Zhao, S-J
    Zhao, H-D
    Li, J.
    Zhang, H.
    Gao, D-T
    Wang, Q.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (21) : 7314 - 7322
  • [26] Posttranscriptional regulation of tetraspanins CD151 & CD9 in breast & prostate cancers
    Bond, Danielle R.
    Passfield, Crystal
    Cairns, Murray
    Ashman, Leonie K.
    Weidenhofer, Judith
    CANCER RESEARCH, 2014, 74 (19)
  • [27] Genetic Ablation of the Tetraspanin CD151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP Model
    Copeland, Ben T.
    Bowman, Matthew J.
    Ashman, Leonie K.
    MOLECULAR CANCER RESEARCH, 2013, 11 (01) : 95 - 105
  • [28] Tetraspanin CD151 mediates communication between PC3 prostate cancer cells and osteoblasts
    Grudowska, Alicja
    Czaplinska, Dominika
    Polom, Wojciech
    Matuszewski, Marcin
    Sadej, Rafal
    Skladanowski, Andrzej C.
    ACTA BIOCHIMICA POLONICA, 2017, 64 (01) : 135 - 141
  • [29] Use of tetraspanins CD151 and CD9 as biomarkers for breast cancer
    Bond, Danielle
    Brzozowski, Joshua
    Skelding, Kathryn
    Roselli, Severine
    Weidenhofer, Judith
    BREAST CANCER MANAGEMENT, 2014, 3 (02) : 123 - 126
  • [30] The role of glycosylation of CD151 in the malignant behavior of breast cancer cells
    Yin, Yuanqin
    Ohkawa, Yuki
    Maeda, Kento
    Kanto, Noriko
    Okamoto, Miki
    Harada, Yoichiro
    Kuribara, Taiki
    Taniguchi, Naoyuki
    CANCER SCIENCE, 2024, 115 : 1874 - 1874
12345